Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction - Wikidata - wikimedia - TriplyDB

Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction

Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction

http://www.wikidata.org/entity/Q28366894

about

Cardiovascular outcomes in high-risk patients without heart failure treated with ARBs: a systematic review and meta-analysis.Angiotensin receptor blockers and risk of myocardial infarction: systematic review.Angiotensin II Type 1 receptor antagonists in chronic heart failure.Recent advances in the secondary prevention of coronary heart disease.Losartan in cardiovascular disease.Efficacy and safety of oral candesartan cilexetil in patients with congestive heart failure.Effects of pre-, peri-, and postmyocardial infarction treatment with losartan in rats: effect of dose on survival, ventricular arrhythmias, function, and remodeling.

P2860

Q33403831-92D87A0A-4D42-48DC-9F52-FDA3FD25B71D Q34081519-D4788E0B-C96C-4AAB-9852-BFE66AF402F9 Q34628700-15C632D8-2923-4E83-B01F-1F8DE721155A Q35925701-9CA1A72C-4C88-4981-B94A-B21A389206F2 Q37608510-7FC0E980-B463-4FF7-9132-FEC3BDD1E276 Q44648444-49B977E2-0B3E-4E71-8010-20A4FD4255AA Q45147874-827910A0-A128-4FBC-A0A9-4D47FB6CE8FE

P2860

Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction

http://www.wikidata.org/entity/Q28366894

description

2001 nî lūn-bûn

@nan

2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction

@ast

Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction

@en

Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction

@nl

type

label

Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction

@ast

Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction

@en

Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction

@nl

prefLabel

Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction

@ast

Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction

@en

Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction

@nl

P1433

Q28366894-9675499F-C06D-4442-91E9-F70A8916164E

P1476

Q28366894-963F5127-5AC0-441B-932B-EBA1D6D4ABB2

P2093

Q28366894-69CD94AB-0B6B-4925-A291-729BDC5924FE

P2860

Q28366894-05395F63-36B6-4D94-957D-9421DFD349C1

Q28366894-0FD52996-C4A8-4031-B982-F003110BF117

Q28366894-269858AA-22D1-4073-9BA3-785B252EB68E

Q28366894-3B02223F-EFFF-49C3-A38C-F8140FA8AFF8

Q28366894-85211CA9-339C-4290-92CC-A00FAED55F3C

Q28366894-92FA5FE7-7819-4925-B96F-40C2F8620A53

Q28366894-9E6452A4-10ED-4B56-B261-067FEA687868

Q28366894-B49B52A9-0E5E-43FB-8D8B-4421C5DCDF9D

Q28366894-C024FCA8-F9D3-473D-9CF1-B402C47D8B04

Q28366894-C7E6A96B-9BD4-473D-A0C4-CF3A095DF23D

P304

Q28366894-28FDF825-3E82-48AC-883B-DB4F95040C6C

P31

Q28366894-2E4A1BC5-C797-4004-BE7C-54286913018B

P356

Q28366894-6683B9C7-386D-459E-B21C-9B6CA9FB42EE

P407

Q28366894-66BBF20B-82D4-4482-B436-746DED3AEF48

P433

Q28366894-F6A05E90-B8C4-481A-90F8-4331E32CBE0C

P478

Q28366894-10F51C26-1984-404A-8F5B-9C27C965B1D5

P577

Q28366894-BEAC5700-39D0-45FC-BBD6-EA16D0E0A8AC

P5875

Q28366894-BA1119A9-6FBF-4456-AB3B-20EAB05DCD63

P698

Q28366894-87951E57-2E7B-466A-A720-85260B622304

P921

Q28366894-B7D636B3-70B7-4A85-8C6D-13B6438121B0

Q28366894-DFB73BA1-2E2B-4E84-94DB-6CFC4FA50103

P932

Q28366894-835BD401-E2BE-4414-8DF0-6811F7958253

P356

P1433

P1476

Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction

@en

P2093

J J McMurray

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study--ELITE II

Comparison of baseline data, initial course, and management: losartan versus captopril following acute myocardial infarction (The OPTIMAAL Trial). OPTIMAAL Trial Steering Committee and Investigators. Optimal Trial in Myocardial Infarction with the A

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. The replacement of angiotensin converting enzyme inhibition (REPLACE) i

The safety and tolerability of candesartan cilexetil in CHF.

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial.

Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study.

Valsartan in acute myocardial infarction trial (VALIANT): rationale and design.

Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure.

P304

97-103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/HEART.86.1.97

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P577

2001-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11928610

http://www.w3.org/2001/XMLSchema#string

P698

11410575

http://www.w3.org/2001/XMLSchema#string

P921

P932

1729819

http://www.w3.org/2001/XMLSchema#string